Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Histone H3 lysine 4 methylation signature associated with human undernutrition.

Uchiyama R, Kupkova K, Shetty SJ, Linford AS, Pray-Grant MG, Wagar LE, Davis MM, Haque R, Gaultier A, Mayo MW, Grant PA, Petri WA Jr, Bekiranov S, Auble DT.

Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11264-E11273. doi: 10.1073/pnas.1722125115. Epub 2018 Nov 12.

2.

The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK.

Amin EM, Liu Y, Deng S, Tan KS, Chudgar N, Mayo MW, Sanchez-Vega F, Adusumilli PS, Schultz N, Jones DR.

Sci Signal. 2017 Sep 19;10(497). pii: eaah3941. doi: 10.1126/scisignal.aah3941.

3.

Preparation and Testing of Impedance-based Fluidic Biochips with RTgill-W1 Cells for Rapid Evaluation of Drinking Water Samples for Toxicity.

Brennan LM, Widder MW, McAleer MK, Mayo MW, Greis AP, van der Schalie WH.

J Vis Exp. 2016 Mar 7;(109). doi: 10.3791/53555.

4.

CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.

Liu Y, Amin EB, Mayo MW, Chudgar NP, Bucciarelli PR, Kadota K, Adusumilli PS, Jones DR.

Cancer Res. 2016 May 1;76(9):2675-86. doi: 10.1158/0008-5472.CAN-15-2888. Epub 2016 Mar 15.

5.

Development of a fluorescent enzyme-linked DNA aptamer-magnetic bead sandwich assay and portable fluorometer for sensitive and rapid listeria detection.

Bruno JG, Phillips T, Montez T, Garcia A, Sivils JC, Mayo MW, Greis A; Metrix360 Laboratories.

J Fluoresc. 2015 Jan;25(1):173-83. doi: 10.1007/s10895-014-1495-8. Epub 2014 Dec 17.

PMID:
25511112
6.

Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.

Wamsley JJ, Kumar M, Allison DF, Clift SH, Holzknecht CM, Szymura SJ, Hoang SA, Xu X, Moskaluk CA, Jones DR, Bekiranov S, Mayo MW.

Cancer Res. 2015 Jan 15;75(2):426-35. doi: 10.1158/0008-5472.CAN-13-2702. Epub 2014 Nov 28.

7.

Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.

Liu Y, Mayo MW, Xiao A, Hall EH, Amin EB, Kadota K, Adusumilli PS, Jones DR.

Mol Cell Biol. 2015 Jan;35(1):303-17. doi: 10.1128/MCB.00869-14. Epub 2014 Nov 3.

8.

Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.

Hall EH, Liu Y, Xiao A, Shock L, Brautigan DL, Mayo MW, Adusumilli PS, Jones DR.

PLoS One. 2014 Apr 24;9(4):e95869. doi: 10.1371/journal.pone.0095869. eCollection 2014.

9.

Regulation of the mitogen-activated protein kinase kinase (MEK)-1 by NAD(+)-dependent deacetylases.

Yeung F, Ramsey CS, Popko-Scibor AE, Allison DF, Gray LG, Shin M, Kumar M, Li D, McCubrey JA, Mayo MW.

Oncogene. 2015 Feb 5;34(6):798-804. doi: 10.1038/onc.2014.39. Epub 2014 Mar 31.

10.

Development of a fluorescent enzyme-linked DNA aptamer-magnetic bead sandwich assay and portable fluorometer for sensitive and rapid leishmania detection in sandflies.

Bruno JG, Richarte AM, Phillips T, Savage AA, Sivils JC, Greis A, Mayo MW.

J Fluoresc. 2014 Jan;24(1):267-77. doi: 10.1007/s10895-013-1315-6. Epub 2013 Nov 13.

PMID:
24222436
11.

Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition.

Cieślik M, Hoang SA, Baranova N, Chodaparambil S, Kumar M, Allison DF, Xu X, Wamsley JJ, Gray L, Jones DR, Mayo MW, Bekiranov S.

Epigenetics Chromatin. 2013 Sep 2;6(1):28. doi: 10.1186/1756-8935-6-28.

12.

NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells.

Kumar M, Allison DF, Baranova NN, Wamsley JJ, Katz AJ, Bekiranov S, Jones DR, Mayo MW.

PLoS One. 2013 Jul 30;8(7):e68597. doi: 10.1371/journal.pone.0068597. Print 2013.

13.

BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.

Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, Stelow EB, Jones DR.

Cancer Res. 2013 Feb 15;73(4):1308-17. doi: 10.1158/0008-5472.CAN-12-2489. Epub 2012 Dec 26.

14.

Global epigenetic changes induced by SWI2/SNF2 inhibitors characterize neomycin-resistant mammalian cells.

Dutta P, Tanti GK, Sharma S, Goswami SK, Komath SS, Mayo MW, Hockensmith JW, Muthuswami R.

PLoS One. 2012;7(11):e49822. doi: 10.1371/journal.pone.0049822. Epub 2012 Nov 28.

15.

A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer.

Margalef P, Fernández-Majada V, Villanueva A, Garcia-Carbonell R, Iglesias M, López L, Martínez-Iniesta M, Villà-Freixa J, Mulero MC, Andreu M, Torres F, Mayo MW, Bigas A, Espinosa L.

Cell Rep. 2012 Oct 25;2(4):840-54. doi: 10.1016/j.celrep.2012.08.028. Epub 2012 Oct 4.

16.

Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-κB acetylation and transcription.

Allison DF, Wamsley JJ, Kumar M, Li D, Gray LG, Hart GW, Jones DR, Mayo MW.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16888-93. doi: 10.1073/pnas.1208468109. Epub 2012 Oct 1.

17.

PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes.

Locke LW, Mayo MW, Yoo AD, Williams MB, Berr SS.

Biomaterials. 2012 Nov;33(31):7785-93. doi: 10.1016/j.biomaterials.2012.07.022. Epub 2012 Jul 26.

PMID:
22840225
18.

Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.

Glidden EJ, Gray LG, Vemuru S, Li D, Harris TE, Mayo MW.

J Biol Chem. 2012 Jan 2;287(1):581-8. doi: 10.1074/jbc.M111.304337. Epub 2011 Nov 14.

19.

Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.

Liu Y, Mayo MW, Nagji AS, Smith PW, Ramsey CS, Li D, Jones DR.

Oncogene. 2012 Mar 1;31(9):1143-54. doi: 10.1038/onc.2011.308. Epub 2011 Jul 18.

20.

Evaluation of molecular markers of mesenchymal phenotype in melanoma.

Mikesh LM, Kumar M, Erdag G, Hogan KT, Molhoek KR, Mayo MW, Slingluff CL Jr.

Melanoma Res. 2010 Dec;20(6):485-95. doi: 10.1097/CMR.0b013e32833fafb4.

21.

Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression.

Xu X, Hoang S, Mayo MW, Bekiranov S.

BMC Bioinformatics. 2010 Jul 23;11:396. doi: 10.1186/1471-2105-11-396.

22.

The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors.

Sturgill TW, Stoddard PB, Cohn SM, Mayo MW.

Mol Cancer. 2010 May 11;9:104. doi: 10.1186/1476-4598-9-104.

23.

StIKKing together: do multiple IKK pathways cooperate in the DNA-damage response?

Allison DF, Mayo MW.

Mol Cell. 2010 Feb 26;37(4):453-4. doi: 10.1016/j.molcel.2010.02.004.

24.

GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA.

Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, Repaka A, Mayo MW, Burstein E.

Genes Dev. 2009 Apr 1;23(7):849-61. doi: 10.1101/gad.1748409.

25.

Copine-I represses NF-kappaB transcription by endoproteolysis of p65.

Ramsey CS, Yeung F, Stoddard PB, Li D, Creutz CE, Mayo MW.

Oncogene. 2008 Jun 5;27(25):3516-26. doi: 10.1038/sj.onc.1211030. Epub 2008 Jan 21.

PMID:
18212740
26.

LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.

Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG.

Cancer Cell. 2007 Sep;12(3):239-51.

27.

Aberrant cytoplasmic localization of N-CoR in colorectal tumors.

Fernández-Majada V, Pujadas J, Vilardell F, Capella G, Mayo MW, Bigas A, Espinosa L.

Cell Cycle. 2007 Jul 15;6(14):1748-52. Epub 2007 May 10.

PMID:
17630505
28.

Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer.

Fernández-Majada V, Aguilera C, Villanueva A, Vilardell F, Robert-Moreno A, Aytés A, Real FX, Capella G, Mayo MW, Espinosa L, Bigas A.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):276-81. Epub 2006 Dec 26. Erratum in: Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5650.

29.

IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.

Hoberg JE, Popko AE, Ramsey CS, Mayo MW.

Mol Cell Biol. 2006 Jan;26(2):457-71.

30.

COMMD proteins, a novel family of structural and functional homologs of MURR1.

Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, Komarck CM, Maine GN, Wilkinson JC, Mayo MW, Duckett CS.

J Biol Chem. 2005 Jun 10;280(23):22222-32. Epub 2005 Mar 30.

31.

Transcriptional repression of TFF1 in gastric epithelial cells by CCAAT/enhancer binding protein-beta.

Sankpal NV, Mayo MW, Powell SM.

Biochim Biophys Acta. 2005 Apr 5;1728(1-2):1-10.

PMID:
15777639
32.
33.

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW.

EMBO J. 2004 Jun 16;23(12):2369-80. Epub 2004 May 20.

34.

Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.

Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1078-86.

36.

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway.

Mayo MW, Denlinger CE, Broad RM, Yeung F, Reilly ET, Shi Y, Jones DR.

J Biol Chem. 2003 May 23;278(21):18980-9. Epub 2003 Mar 20.

37.

A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity.

Regan SE, Broad M, Byford AM, Lankford AR, Cerniway RJ, Mayo MW, Matherne GP.

Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H859-66.

38.

Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation.

Jones DR, Broad RM, Comeau LD, Parsons SJ, Mayo MW.

J Thorac Cardiovasc Surg. 2002 Feb;123(2):310-7.

39.

PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit.

Mayo MW, Madrid LV, Westerheide SD, Jones DR, Yuan XJ, Baldwin AS Jr, Whang YE.

J Biol Chem. 2002 Mar 29;277(13):11116-25. Epub 2002 Jan 17.

40.

The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.

Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin AS Jr.

Mol Cell Biol. 2001 Dec;21(24):8428-36.

41.

Ras regulation of NF-kappa B and apoptosis.

Mayo MW, Norris JL, Baldwin AS.

Methods Enzymol. 2001;333:73-87. Review. No abstract available.

PMID:
11400356
42.
43.

A review of molecular recognition technologies for detection of biological threat agents.

Iqbal SS, Mayo MW, Bruno JG, Bronk BV, Batt CA, Chambers JP.

Biosens Bioelectron. 2000;15(11-12):549-78. Review.

PMID:
11213217
44.

Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription.

Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, Wang CY.

J Cell Biol. 2001 Jan 8;152(1):87-96.

45.

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

Jones DR, Broad RM, Madrid LV, Baldwin AS Jr, Mayo MW.

Ann Thorac Surg. 2000 Sep;70(3):930-6; discussion 936-7.

PMID:
11016336
46.

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.

Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr.

Science. 2000 Sep 29;289(5488):2363-6.

47.

The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance.

Mayo MW, Baldwin AS.

Biochim Biophys Acta. 2000 Mar 27;1470(2):M55-62. Review.

PMID:
10722927
48.

Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW.

Mol Cell Biol. 2000 Mar;20(5):1626-38.

49.

Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding.

Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr.

J Biol Chem. 1999 Nov 5;274(45):31868-74.

50.

Supplemental Content

Support Center